- Home
- PROK vs AMTD Comparison
PROK vs AMTD Comparison
Compare PROK & AMTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- AMTD
- Stock Information
- Founded
- PROK 2015
- AMTD 2003
- Country
- PROK United States
- AMTD France
- Employees
- PROK N/A
- AMTD N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- AMTD
- Sector
- PROK Health Care
- AMTD
- Exchange
- PROK Nasdaq
- AMTD Nasdaq
- Market Cap
- PROK 85.5M
- AMTD 80.2M
- IPO Year
- PROK N/A
- AMTD 2019
- Fundamental
- Price
- PROK $0.58
- AMTD $1.02
- Analyst Decision
- PROK Hold
- AMTD
- Analyst Count
- PROK 3
- AMTD 0
- Target Price
- PROK $3.50
- AMTD N/A
- AVG Volume (30 Days)
- PROK 1.6M
- AMTD 73.4K
- Earning Date
- PROK 08-08-2025
- AMTD 07-07-2025
- Dividend Yield
- PROK N/A
- AMTD N/A
- EPS Growth
- PROK N/A
- AMTD N/A
- EPS
- PROK N/A
- AMTD 0.76
- Revenue
- PROK $306,000.00
- AMTD $67,032,000.00
- Revenue This Year
- PROK $54.34
- AMTD N/A
- Revenue Next Year
- PROK N/A
- AMTD N/A
- P/E Ratio
- PROK N/A
- AMTD $1.29
- Revenue Growth
- PROK N/A
- AMTD N/A
- 52 Week Low
- PROK $0.46
- AMTD $0.92
- 52 Week High
- PROK $2.59
- AMTD $1.79
- Technical
- Relative Strength Index (RSI)
- PROK 39.22
- AMTD 46.23
- Support Level
- PROK $0.54
- AMTD $0.95
- Resistance Level
- PROK $0.90
- AMTD $1.10
- Average True Range (ATR)
- PROK 0.13
- AMTD 0.07
- MACD
- PROK -0.03
- AMTD -0.00
- Stochastic Oscillator
- PROK 8.06
- AMTD 39.44
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About AMTD AMTD IDEA Group each representing six (6)
AMTD IDEA Group is a financial institution operating in five business segments: The capital market solutions segment assists customers in raising funds through equity and debt financing, private placements, and debt issuances. The digital solutions and other services segment provides institutional and corporate clients with paid access to enhance investor communication and relations, corporate communication also provides digital financial solution services. The Media and entertainment segment offers print and digital advertising campaigns, licensing, and marketing services including branded content, video production. The hotel operations, hospitality, and VIP services segment engages in hotel investments, hotel operations, hospitality, and VIP services; and Strategic investment segment.